Tumor cell-derived GM-CSF promotes Sp1 binding to the FCGR2B promoter to increase the expression of FcγRIIB that subsequently activates the Stat3 signaling pathway to promote generation of gMDSCs in the TME. The gene discussed is STAT3; the disease is neoplasm.